L26/P-217 Viscosity-modulated, low-cryoprotectant vitrification improves mitochondrial function and post-warming developmental competence of bovine and human oocytes and embryos
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Miki und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do revisions in cryoprotectant composition and vitrification/warming protocols improve the developmental competence of bovine and human oocytes and embryos? Summary answer A viscosity-modulated, low-cryoprotectant vitrification system improves post-warming developmental competence by controlling rehydration kinetics, reducing necrosis, and preserving mitochondrial function. What is known already Vitrification and warming impair the developmental competence of oocytes and embryos. Because these procedures are time-consuming, shortened vitrification and warming protocols have recently gained attention to reduce exposure to non-physiological conditions, including low temperature, high osmolality, and cytotoxic cryoprotectants. Although several clinical studies have reported comparable pregnancy outcomes with shortened protocols, in vitro studies have raised concerns regarding adverse effects induced by shortened protocols, such as compromised mitochondrial function and increased necrosis. These findings indicate the need for a novel vitrification system that improves embryonic and clinical outcomes while optimising laboratory workflow efficiency. Study design, size, duration A novel oocyte vitrification (NOV) system was established using bovine oocytes. Developmental competence of oocytes vitrified–warmed using the Cryotop method (control), ultra-fast vitrification/warming (shortened), or NOV protocols was assessed by parthenogenetic activation. Additionally, 207 donated human blastocysts were used to establish a novel embryo vitrification (NEV) system. Viability of blastocysts vitrified–warmed with Cryotop (control), conventional vitrification/ultra-fast warming (shortened), or NEV protocols was evaluated using an in vitro outgrowth model. Participants/materials, setting, methods The novel vitrification method utilised a revised cryoprotectant composition with a simplified two-step protocol (2 + 2 min). For the NOV system, vitrification solutions A and B contained 5% and 7.5% dimethyl sulfoxide (DMSO), respectively, supplemented with 2% polyvinylpyrrolidone (PVP). For the NEV system, PVP was reduced to 0.05%, while DMSO concentrations remained identical to those of NOV. Warming was performed in a single step using 1 M trehalose for 2 min in a PVP-containing solution (0.5%). Main results and the role of chance Solution viscosity was higher in the NOV and NEV systems than in the Cryotop solution (P < 0.0001–0.0097). In bovine oocytes, survival rates were comparable among the control (99.4%), shortened (99.5%), and NOV (100%) groups. However, the developmental rate to the expanded blastocyst stage was higher in the NOV group (31.4%) than in the control (17.4%) and shortened (18.3%) groups (both P < 0.0001). In human blastocysts, adhesion rates were higher in the NEV group than in the control group (P = 0.0448). The outgrowth area was larger in the NEV group than in the control and shortened groups (P = 0.0303–0.0386). The outgrowth degeneration rate was higher in the shortened group than in the control group (P = 0.0291), whereas no difference was observed between the control and NEV groups. The shortened protocol induced rapid rehydration, whereas the NEV group exhibited more gradual recovery. The proportion of necrotic cells was higher in the shortened group than in the control and NEV groups (P = 0.0022–0.0173). Mitochondrial membrane potential was higher in the NEV group than in the control and shortened groups (P = 0.0002–0.0062). Limitations, reasons for caution The developmental competence of vitrified–warmed oocytes was assessed using parthenogenetic activation; therefore, future studies should examine competence via insemination. As this was an experimental study using discarded vitrified human blastocysts, further clinical research is required to validate our findings and confirm their clinical efficacy. Wider implications of the findings Modulating cryoprotectant composition and solution viscosity introduces a novel strategy that enhances oocyte developmental competence and blastocyst implantation potential after vitrification. By controlling rehydration kinetics, this approach reduces necrosis and preserves metabolic function, enabling optimisation of cryopreservation protocols while shortening procedure time and facilitating adoption into routine laboratory practice. Trial registration number No
Zitieren
APA
Miki, T., Ezoe, K., Fujiwara, N., Kuroda, T., & Kato, K. (2026). L26/P-217 Viscosity-modulated, low-cryoprotectant vitrification improves mitochondrial function and post-warming developmental competence of bovine and human oocytes and embryos. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.553
Vancouver
Miki T, Ezoe K, Fujiwara N, Kuroda T, Kato K. L26/P-217 Viscosity-modulated, low-cryoprotectant vitrification improves mitochondrial function and post-warming developmental competence of bovine and human oocytes and embryos. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.553
BibTeX
@article{Miki2026,
author = {Miki, T. and Ezoe, K. and Fujiwara, N. and Kuroda, T. and Kato, K.},
title = {L26/P-217 Viscosity-modulated, low-cryoprotectant vitrification improves mitochondrial function and post-warming developmental competence of bovine and human oocytes and embryos},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.553}
}
EUVIMED